Bryan Richard Hinton - Jan 3, 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Technology Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jan 3, 2022
Transactions value $
-$3,072
Form type
4
Date filed
1/5/2022, 06:28 PM
Previous filing
Dec 29, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $1.14K +106 +1.13% $10.78 9.48K Jan 3, 2022 Direct
transaction HCAT Common Stock Sale -$4.21K -106 -1.12% $39.76 9.38K Jan 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -106 -20.04% $0.00 423 Jan 3, 2022 Common Stock 106 $10.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
F2 25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.